nodes	percent_of_prediction	percent_of_DWPC	metapath
Valaciclovir—Renal pain—Riluzole—amyotrophic lateral sclerosis	0.0284	0.0369	CcSEcCtD
Valaciclovir—Platelet count decreased—Riluzole—amyotrophic lateral sclerosis	0.0251	0.0326	CcSEcCtD
Valaciclovir—Tooth disorder—Riluzole—amyotrophic lateral sclerosis	0.0231	0.0299	CcSEcCtD
Valaciclovir—SLC6A14—Na+/Cl- dependent neurotransmitter transporters—SLC6A1—amyotrophic lateral sclerosis	0.0215	0.0939	CbGpPWpGaD
Valaciclovir—Mania—Riluzole—amyotrophic lateral sclerosis	0.0206	0.0267	CcSEcCtD
Valaciclovir—Accidental injury—Riluzole—amyotrophic lateral sclerosis	0.0169	0.0219	CcSEcCtD
Valaciclovir—Cough increased—Riluzole—amyotrophic lateral sclerosis	0.0163	0.0212	CcSEcCtD
Valaciclovir—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.0158	0.0205	CcSEcCtD
Valaciclovir—Phosphatase alkaline increased—Riluzole—amyotrophic lateral sclerosis	0.015	0.0194	CcSEcCtD
Valaciclovir—SLC6A14—Amine compound SLC transporters—SLC6A1—amyotrophic lateral sclerosis	0.0149	0.0652	CbGpPWpGaD
Valaciclovir—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.0144	0.0187	CcSEcCtD
Valaciclovir—Aplastic anaemia—Riluzole—amyotrophic lateral sclerosis	0.014	0.0182	CcSEcCtD
Valaciclovir—Coma—Riluzole—amyotrophic lateral sclerosis	0.0137	0.0177	CcSEcCtD
Valaciclovir—SLC6A14—Amino acid and oligopeptide SLC transporters—SLC1A2—amyotrophic lateral sclerosis	0.0133	0.0581	CbGpPWpGaD
Valaciclovir—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.0125	0.0162	CcSEcCtD
Valaciclovir—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.0124	0.016	CcSEcCtD
Valaciclovir—Eczema—Riluzole—amyotrophic lateral sclerosis	0.0121	0.0157	CcSEcCtD
Valaciclovir—Injury—Riluzole—amyotrophic lateral sclerosis	0.0118	0.0153	CcSEcCtD
Valaciclovir—SLC6A14—Amino acid and oligopeptide SLC transporters—SLC1A3—amyotrophic lateral sclerosis	0.0113	0.0494	CbGpPWpGaD
Valaciclovir—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.0109	0.0141	CcSEcCtD
Valaciclovir—Migraine—Riluzole—amyotrophic lateral sclerosis	0.0107	0.0139	CcSEcCtD
Valaciclovir—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.0106	0.0138	CcSEcCtD
Valaciclovir—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.0105	0.0136	CcSEcCtD
Valaciclovir—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.0102	0.0132	CcSEcCtD
Valaciclovir—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.0101	0.0131	CcSEcCtD
Valaciclovir—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.01	0.013	CcSEcCtD
Valaciclovir—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00978	0.0127	CcSEcCtD
Valaciclovir—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00958	0.0124	CcSEcCtD
Valaciclovir—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00938	0.0122	CcSEcCtD
Valaciclovir—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00903	0.0117	CcSEcCtD
Valaciclovir—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.009	0.0117	CcSEcCtD
Valaciclovir—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00857	0.0111	CcSEcCtD
Valaciclovir—Depression—Riluzole—amyotrophic lateral sclerosis	0.00834	0.0108	CcSEcCtD
Valaciclovir—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00816	0.0106	CcSEcCtD
Valaciclovir—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00813	0.0106	CcSEcCtD
Valaciclovir—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00798	0.0103	CcSEcCtD
Valaciclovir—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00791	0.0103	CcSEcCtD
Valaciclovir—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00785	0.0102	CcSEcCtD
Valaciclovir—SLC6A14—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A2—amyotrophic lateral sclerosis	0.00783	0.0342	CbGpPWpGaD
Valaciclovir—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00753	0.00977	CcSEcCtD
Valaciclovir—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00751	0.00974	CcSEcCtD
Valaciclovir—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00747	0.00969	CcSEcCtD
Valaciclovir—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00746	0.00967	CcSEcCtD
Valaciclovir—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00742	0.00962	CcSEcCtD
Valaciclovir—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.0074	0.0096	CcSEcCtD
Valaciclovir—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00736	0.00955	CcSEcCtD
Valaciclovir—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.0071	0.00921	CcSEcCtD
Valaciclovir—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00678	0.0088	CcSEcCtD
Valaciclovir—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00677	0.00878	CcSEcCtD
Valaciclovir—Chills—Riluzole—amyotrophic lateral sclerosis	0.00674	0.00874	CcSEcCtD
Valaciclovir—SLC6A14—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A3—amyotrophic lateral sclerosis	0.00666	0.0291	CbGpPWpGaD
Valaciclovir—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00664	0.00861	CcSEcCtD
Valaciclovir—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00644	0.00836	CcSEcCtD
Valaciclovir—Tension—Riluzole—amyotrophic lateral sclerosis	0.00642	0.00832	CcSEcCtD
Valaciclovir—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00635	0.00824	CcSEcCtD
Valaciclovir—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00632	0.0082	CcSEcCtD
Valaciclovir—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC1A2—amyotrophic lateral sclerosis	0.00629	0.0275	CbGpPWpGaD
Valaciclovir—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00613	0.00795	CcSEcCtD
Valaciclovir—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00604	0.00784	CcSEcCtD
Valaciclovir—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00601	0.00779	CcSEcCtD
Valaciclovir—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00597	0.00775	CcSEcCtD
Valaciclovir—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00585	0.00759	CcSEcCtD
Valaciclovir—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC1A2—amyotrophic lateral sclerosis	0.00584	0.0255	CbGpPWpGaD
Valaciclovir—SLC6A14—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.00584	0.0255	CbGpPWpGaD
Valaciclovir—SLC6A14—NRF2 pathway—GSR—amyotrophic lateral sclerosis	0.00575	0.0251	CbGpPWpGaD
Valaciclovir—Cough—Riluzole—amyotrophic lateral sclerosis	0.00571	0.0074	CcSEcCtD
Valaciclovir—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00567	0.00735	CcSEcCtD
Valaciclovir—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00565	0.00732	CcSEcCtD
Valaciclovir—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00557	0.00722	CcSEcCtD
Valaciclovir—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00557	0.00722	CcSEcCtD
Valaciclovir—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00557	0.00722	CcSEcCtD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00553	0.00717	CcSEcCtD
Valaciclovir—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00544	0.00706	CcSEcCtD
Valaciclovir—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00538	0.00698	CcSEcCtD
Valaciclovir—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC1A3—amyotrophic lateral sclerosis	0.00535	0.0234	CbGpPWpGaD
Valaciclovir—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00534	0.00692	CcSEcCtD
Valaciclovir—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00534	0.00692	CcSEcCtD
Valaciclovir—Infection—Riluzole—amyotrophic lateral sclerosis	0.0053	0.00688	CcSEcCtD
Valaciclovir—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00523	0.00679	CcSEcCtD
Valaciclovir—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00523	0.00678	CcSEcCtD
Valaciclovir—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00521	0.00676	CcSEcCtD
Valaciclovir—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00518	0.00672	CcSEcCtD
Valaciclovir—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00509	0.0066	CcSEcCtD
Valaciclovir—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC1A3—amyotrophic lateral sclerosis	0.00497	0.0217	CbGpPWpGaD
Valaciclovir—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00486	0.00631	CcSEcCtD
Valaciclovir—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00483	0.00626	CcSEcCtD
Valaciclovir—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00479	0.00622	CcSEcCtD
Valaciclovir—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00476	0.00617	CcSEcCtD
Valaciclovir—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00474	0.00615	CcSEcCtD
Valaciclovir—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.0047	0.00609	CcSEcCtD
Valaciclovir—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00464	0.00602	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00461	0.00598	CcSEcCtD
Valaciclovir—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.0046	0.00597	CcSEcCtD
Valaciclovir—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00456	0.00592	CcSEcCtD
Valaciclovir—Pain—Riluzole—amyotrophic lateral sclerosis	0.00456	0.00592	CcSEcCtD
Valaciclovir—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.0044	0.0057	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00436	0.00566	CcSEcCtD
Valaciclovir—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00424	0.0055	CcSEcCtD
Valaciclovir—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00422	0.00547	CcSEcCtD
Valaciclovir—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00422	0.00547	CcSEcCtD
Valaciclovir—SLC6A14—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	0.00421	0.0184	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00419	0.0183	CbGpPWpGaD
Valaciclovir—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00393	0.0051	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00383	0.0167	CbGpPWpGaD
Valaciclovir—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00383	0.00497	CcSEcCtD
Valaciclovir—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00378	0.0049	CcSEcCtD
Valaciclovir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A2—amyotrophic lateral sclerosis	0.00371	0.0162	CbGpPWpGaD
Valaciclovir—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00365	0.00474	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00356	0.0155	CbGpPWpGaD
Valaciclovir—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00353	0.00458	CcSEcCtD
Valaciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.0035	0.0153	CbGpPWpGaD
Valaciclovir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A2—amyotrophic lateral sclerosis	0.00344	0.015	CbGpPWpGaD
Valaciclovir—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00339	0.0044	CcSEcCtD
Valaciclovir—Rash—Riluzole—amyotrophic lateral sclerosis	0.00336	0.00436	CcSEcCtD
Valaciclovir—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00336	0.00436	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00335	0.0146	CbGpPWpGaD
Valaciclovir—Headache—Riluzole—amyotrophic lateral sclerosis	0.00334	0.00434	CcSEcCtD
Valaciclovir—SLC6A14—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.00325	0.0142	CbGpPWpGaD
Valaciclovir—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00317	0.00411	CcSEcCtD
Valaciclovir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A3—amyotrophic lateral sclerosis	0.00315	0.0138	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00302	0.0132	CbGpPWpGaD
Valaciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00298	0.013	CbGpPWpGaD
Valaciclovir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A3—amyotrophic lateral sclerosis	0.00292	0.0128	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00276	0.0121	CbGpPWpGaD
Valaciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00265	0.0116	CbGpPWpGaD
Valaciclovir—SLC6A14—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.00254	0.0111	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.0023	0.01	CbGpPWpGaD
Valaciclovir—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.00228	0.00995	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00195	0.00849	CbGpPWpGaD
Valaciclovir—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.0019	0.0083	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00187	0.00814	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00187	0.00814	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00178	0.00777	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.00174	0.00759	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00171	0.00745	CbGpPWpGaD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00166	0.00723	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00165	0.00722	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00165	0.00722	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00159	0.00692	CbGpPWpGaD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00154	0.00671	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00151	0.0066	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00151	0.0066	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00149	0.00651	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00147	0.00643	CbGpPWpGaD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00141	0.00615	CbGpPWpGaD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00137	0.00597	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—DAO—amyotrophic lateral sclerosis	0.00135	0.00589	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00135	0.00588	CbGpPWpGaD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00131	0.0057	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00131	0.0057	CbGpPWpGaD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00125	0.00548	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00121	0.00529	CbGpPWpGaD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00116	0.00508	CbGpPWpGaD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00116	0.00507	CbGpPWpGaD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00114	0.00498	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00108	0.0047	CbGpPWpGaD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00104	0.00452	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00102	0.00446	CbGpPWpGaD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00097	0.00423	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GSR—amyotrophic lateral sclerosis	0.000943	0.00412	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.0009	0.00393	CbGpPWpGaD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000864	0.00377	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000859	0.00375	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000841	0.00367	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000781	0.00341	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000775	0.00338	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000715	0.00312	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000715	0.00312	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000707	0.00309	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000695	0.00303	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000664	0.0029	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000664	0.0029	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000638	0.00278	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000592	0.00258	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000591	0.00258	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000591	0.00258	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00058	0.00253	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000526	0.0023	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000493	0.00215	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000493	0.00215	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000484	0.00211	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000439	0.00192	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000416	0.00182	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000383	0.00167	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—APOE—amyotrophic lateral sclerosis	0.000315	0.00137	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000216	0.000941	CbGpPWpGaD
